Division of Bacterial Diseases (DBD) News Bulletin
In This Issue
The International Symposium on Influenza and Other Respiratory Infections 2011 was held August 2-4, 2011 in Beijing, China. Fabiana Pimenta (DBD/RDB) presented, “Laboratory diagnostics on invasive pneumococcal infections: challenges of existing methods and updates.” Chris Van Beneden (DBD/RDB) presented, “Surveillance for pneumococcal and Hib disease in the United States and Asian countries,” “Antimicrobial use: recommendations from CDC’s Get Smart Program and the global community,” and “Impact of pneumococcal conjugate vaccines in the U.S., before and after universal vaccine introduction.”
On August 8-9, 2011, Fabiana Pimenta (DBD/RDB), Bob Pinner (NCEZID) and Chris Van Beneden (DBD/RDB) conducted a site visit of the International Emerging Infections Program (IEIP) Respiratory Surveillance sites in Jingzhou City, Hubei Province, China.
The National Pertussis Workshop: Strategies to Prevent Severe Pertussis in the Next Decade was held August 25-26, 2011 in Sydney, Australia. Tom Clark (DBD/MVPDB) presented “Vaccine efficacy and vaccine schedules: U.S. overview” and “Cocooning – experience and cost-effectiveness: U.S. overview.”
The XVIII Lancefield International Symposium was held September 4-8, 2011 in Palermo, Italy. Chris Van Beneden (DBD/RDB) presented, “Changing landscape of pneumococcal disease following widespread use of conjugate vaccines in the United States” and the poster, “Does a group A streptococcal strain predict the severity of invasive disease?”
The annual Federation of Infectious Disease Societies of Southern Africa meeting was held September 8-11, 2011 in Durban, South Africa. Stephanie Schrag (DBD/RDB) and Jennifer Verani (DBD/RDB) coauthored a poster, “Invasive group B streptococcal disease in South Africa,” which was presented by an external partner.
The WHO Global New Vaccines Surveillance Meeting was held September 11-14, 2011 in Geneva, Switzerland. Tom Clark (DBD/MVPDB) presented “Lessons learned from Burkina Faso meningitis surveillance strengthening.” Rana Hajjeh (DBD/OD), Stephanie Schwartz (DBD/OD), Carla Talarico (DBD/RDB), and Chris Van Beneden (DBD/RDB) also actively participated in this meeting.
The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) was held September 17-20, 2011 in Chicago, Illinois. Nancy Messonnier (DBD/MVPDB) presented, “Control of serogroup A meningococcal disease in Sub-Saharan Africa.” Matt Moore (DBD/RDB) presented, “Early impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old, U.S, 2010.” Chris Van Beneden (DBD/RDB) presented, “An update on postpartum group A streptococcal infections.”
The 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) was held October 20-23, 2011 in Boston, Massachusetts. Amanda Cohn (DBD/MVPDB) presented, “Meningococcal conjugate vaccine: new recommendations and potential for use of conjugate vaccine in infants.” Lara Misegades (DBD/MVPDB) presented, “DTaP effectiveness: results from the California pertussis vaccine effectiveness assessment.” Sara Tartof (DBD/MVPDB) presented, “Rapid rise of incidence rates of pertussis in the five years following complete DTaP vaccination: is immunity waning earlier than expected?” Andrew Terranella (DBD/MVPDB) presented, “Preventing infant pertussis: a decision analysis comparing prenatal vaccination to cocooning.”
Save the Date!
January 27: Cluster of Streptococcus pneumoniae among children living at a psychiatric facility – Rhode Island
February 18: Unexplained respiratory disease outbreak associated with conference in Santa Monica, California – Los Angeles, CA
April 15: Legionellosis outbreak associated with an acute care hospital – Spokane, WA
May 21: Legionnaires’ disease outbreak associated with travel on a cruise ship – New Orleans, LA
September 3: Legionnaires’ disease among guests at Resort X, West Virginia – Chester, WV
September 26: Legionnaires’ disease among residents of a long term care facility, OH – Columbus, OH
October 14: Legionnaires’ disease among travelers to a resort, St. Thomas – Virgin Islands
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.